rift
valley
fever
viru
rvfv
member
genu
phleboviru
within
famili
bunyavirida
caus
period
outbreak
among
livestock
human
subsaharan
african
countri
rvfv
infect
result
high
mortal
abort
rate
domest
rumin
sever
hepat
diseas
also
caus
acut
febril
myalgic
syndrom
hemorrhag
syndrom
ocular
diseas
enceph
human
transmiss
rvfv
human
primarili
mosquitoborn
due
direct
contact
infect
anim
blood
tissu
product
abort
sinc
late
sever
major
outbreak
rift
valley
fever
occur
outsid
subsaharan
africa
eg
egypt
madagascar
saudi
arabia
yemen
recent
outbreak
report
kenya
result
high
report
casefat
ratio
infect
human
rvfv
singlestrand
tripartit
rna
genom
compos
l
segment
l
segment
neg
polar
encod
rnadepend
rna
polymeras
l
antiviralsens
segment
encod
two
envelop
glycoprotein
gn
gc
two
accessori
nsm
suppress
virusinduc
apoptosi
protein
segment
use
ambisens
strategi
gene
express
nonstructur
protein
nss
translat
viralsens
mrna
n
protein
express
antiviralsens
mrna
n
protein
l
protein
essenti
viral
rna
synthesi
nss
protein
suppress
host
innat
immun
function
suppress
host
gene
express
includ
promot
pkr
degrad
experi
use
reassort
virus
attenu
strain
rvfv
wildtyp
wt
rvfv
suggest
rvfv
virul
characterist
mous
polygen
control
studi
use
reassort
virus
wt
strain
rvfv
attenu
rvfv
isol
clone
plaqu
clone
variant
wt
strain
carri
delet
nss
gene
suggest
rvfv
mous
virul
control
segment
import
nss
viral
virul
confirm
use
wt
rvfv
lack
entir
nss
gene
studi
use
wt
rvfv
lack
nsm
gene
show
nsm
also
affect
viru
virul
rat
contrast
gn
gc
envelop
protein
l
protein
contribut
viral
virul
unknown
present
studi
reveal
wt
rvfv
stock
origin
isol
patient
outbreak
rvfv
egypt
made
two
major
viru
popul
singl
nucleotid
substitut
within
gn
gene
singl
nucleotid
differ
gn
gene
wt
rvfv
substanti
affect
viral
mous
virul
furthermor
observ
remark
rapid
emerg
accumul
virulenttyp
viru
mice
inocul
low
virulenttyp
rvfv
sequenc
analysi
rtpcr
product
intracellular
rna
show
sequenc
homogen
three
rna
segment
except
nucleotid
antivir
sens
segment
rna
consist
mixtur
g
residu
fig
independ
clone
rtpcr
product
region
includ
clone
clone
g
respect
suggest
us
viru
stock
consist
roughli
mixtur
two
major
viral
subpopul
one
carri
carri
g
viru
carri
residu
encod
glutam
acid
amino
acid
gn
envelop
protein
carri
g
residu
encod
glycin
sequenc
analysi
clone
pcr
product
also
show
sequenc
heterogen
includ
silent
mutat
alter
amino
acid
sequenc
within
segment
data
shown
reveal
quasispeci
natur
viru
stock
none
nucleotid
heterogen
share
among
clone
data
shown
know
effect
nucleotid
differ
biolog
properti
viru
recov
carri
carri
g
correspond
site
use
revers
genet
system
endogen
express
polymereas
cell
drive
express
viral
rna
protein
transfect
plasmid
sequenc
analysi
entir
l
rna
segment
reveal
virus
expect
primari
sequenc
substanti
differ
plaqu
size
morpholog
detect
among
vero
cell
cell
data
shown
show
similar
replic
kinet
cell
mous
cell
mous
macrophagederiv
cell
fig
titer
roughli
time
higher
human
lung
fibroblast
cell
h
h
pi
fig
also
trend
cpe
induc
less
promin
cpe
induc
given
time
four
cell
line
fig
unpairedttest
three
independ
experi
examin
replic
kinet
cell
h
h
pi
reveal
titer
significantli
higher
p
h
pi
fig
examin
virul
intraperiton
ip
inocul
plaqueform
unit
pfu
viru
five
femal
mice
hank
balanc
salt
solut
hbss
inocul
control
mice
mice
observ
daili
day
pi
fig
none
hbssinocul
mice
die
inocul
pfu
result
death
mice
within
day
pi
one
three
mice
surviv
inocul
pfu
respect
mice
inocul
pfu
die
within
day
pi
infect
pfu
result
surviv
one
four
mice
respect
surpris
none
infect
mice
die
inocul
pfu
four
five
mice
surviv
inocul
pfu
one
mous
surviv
infect
pfu
data
demonstr
highli
virul
mice
wherea
reduc
mous
virul
know
kinet
titer
viru
replic
variou
organ
mice
inocul
ip
pfu
mixtur
pfu
titer
viru
titer
liver
spleen
kidney
sera
brain
determin
day
pi
two
sixteen
mice
use
time
point
fig
mice
infect
mixtur
exhibit
rapid
effici
viru
replic
liver
earli
infect
high
titer
viremia
day
pi
gradual
increas
effici
viru
replic
brain
viru
titer
exceed
pfug
day
pi
effici
viru
replic
also
occur
spleen
kidney
mice
die
day
pi
mice
infect
also
show
rapid
viru
replic
liver
yet
maximum
liver
viru
titer
approxim
time
lower
mice
infect
mixtur
also
titer
sera
kidney
spleen
brain
substanti
lower
viru
titer
correspond
organ
mice
infect
mixtur
unpairedttest
result
show
viru
titer
day
serum
liver
day
spleen
day
kidney
day
brain
mice
statist
lower
p
titer
correspond
organ
mice
next
examin
serumneutr
antibodi
titer
infect
mice
use
neutral
antibodi
assay
viru
group
mice
use
shown
fig
mice
inocul
ip
pfu
mixtur
pfu
titer
less
detect
level
neutral
antibodi
day
pi
contrast
mice
show
low
detect
level
neutral
antibodi
earli
infect
moreov
low
titer
neutral
antibodi
detect
earli
day
pi
mice
although
neutral
antibodi
titer
increas
infect
mice
day
pi
trend
mice
higher
neutral
antibodi
titer
infect
mice
neutral
antibodi
detect
shaminfect
mice
data
shown
perform
crossneutr
assay
determin
effici
antiserum
mice
mice
could
neutral
serum
demonstr
neutral
antibodi
titer
titer
serum
demonstr
titer
obtain
mice
mice
respect
use
control
diluent
normal
mous
serum
convalesc
goat
serum
show
titer
assay
viru
titer
determin
overnight
incub
approxim
pfuml
volum
undilut
antiserum
diluent
tabl
goat
serum
effici
neutral
virus
incub
normal
mous
serum
result
small
reduct
viru
titer
serum
serum
neutral
three
virus
differ
effici
differ
viru
titer
incub
antiserum
incub
normal
serum
shown
within
parenthes
tabl
serum
reduc
titer
pfuml
reduc
titer
pfuml
respect
serum
reduc
titer
pfuml
respect
data
demonstr
mous
antiserum
neutral
homolog
viru
similar
extent
regardless
titer
antiserum
neutral
heterolog
viru
equal
lesser
degre
homolog
viru
serum
abl
neutral
titer
slightli
greater
degre
serum
howev
neither
serum
neutral
equal
neutral
homolog
virus
understand
pathogenesi
perform
histopatholog
ihc
analys
variou
organ
mice
inocul
ip
pfu
mixtur
pfu
titer
variou
time
pi
fig
liver
mice
show
multifoc
hepatocellular
necrosi
promin
aggreg
mononuclear
inflammatori
cell
spars
scatter
viral
antigen
throughout
liver
lobe
earli
day
pi
day
pi
hepatocyt
necrot
posit
viral
antigen
fig
also
sever
hemorrhag
note
throughout
lobe
day
pi
liver
mice
examin
show
less
sever
hepatocellular
damag
liver
taken
earlier
liver
examin
day
pi
show
near
complet
resolut
mice
present
similar
lesion
distribut
viral
antigen
yet
progress
lesion
somewhat
slower
mice
fig
although
mice
focaltomultifoc
hepatocellular
necrosi
day
pi
fig
exhibit
mild
hepat
lesion
compar
mice
mice
among
mice
inocul
mixtur
one
show
sever
hepat
lesion
like
mice
other
mild
hepat
lesion
like
mice
data
shown
spleen
mice
fig
mice
fig
mice
inocul
mixtur
data
shown
character
deplet
lymphocyt
white
pulp
day
pi
day
pi
maximum
deplet
seen
day
pi
presenc
viral
antigen
white
pulp
day
pi
lesion
viral
antigen
detect
spleen
mice
fig
infect
mice
except
mice
moder
nonsuppur
enceph
throughout
brain
day
pi
fig
viral
antigen
detect
earli
day
pi
endotheli
cell
mice
day
pi
viral
antigen
detect
neuron
thalamu
spread
neuron
surround
area
fig
inset
lesion
diagnos
mild
mening
mild
enceph
brain
mice
fig
viral
antigen
detect
throughout
brain
day
pi
kidney
mice
mice
infect
mixtur
show
pyknot
cell
glomeruli
day
pi
fig
infect
mice
viral
antigen
smooth
muscl
interlobular
arcuat
arteri
day
pi
mesangium
glomeruli
day
pi
fig
although
patholog
detect
kidney
mice
viral
antigen
detect
day
mesangium
glomeruli
smooth
muscl
interlobular
arcuat
arteri
day
pi
kidney
mice
show
patholog
infect
mice
exhibit
viral
antigen
day
day
pi
smooth
muscl
interlobular
arcuat
arteri
fig
wherea
viral
antigen
detect
glomeruli
fig
summari
rough
correl
presenc
viral
antigen
viral
titer
given
organ
mice
delay
develop
lesion
show
less
sever
lesion
infect
mous
group
next
examin
whether
virus
accumul
infect
mice
retain
inputviru
genom
sequenc
end
took
advantag
presenc
natur
occur
sac
site
gagctc
includ
residu
underlin
due
singl
nucleotid
substitut
correspond
region
lack
restrict
enzym
site
mice
infect
ip
pfu
n
group
organ
isol
variou
time
pi
rtpcr
product
includ
subject
sac
digest
viru
group
collect
liver
day
pi
spleen
kidney
brain
day
pi
brain
day
pi
rtpcr
product
expect
size
obtain
sampl
mice
fulli
suscept
sac
digest
fig
demonstr
replic
retain
residu
infect
mice
unabl
obtain
rtpcr
product
one
spleen
sampl
day
pi
one
kidney
sampl
day
pi
one
brain
sampl
day
pi
one
brain
sampl
day
pi
mice
data
shown
probabl
due
low
viru
titer
sampl
two
liver
sampl
day
pi
resist
sac
digest
fig
unexpectedli
rtpcr
product
one
liver
sampl
mixtur
sac
isuscept
pcr
product
sac
iresist
product
fig
rtpcr
product
includ
two
spleen
sampl
day
pi
two
brain
sampl
day
pi
two
brain
day
pi
data
shown
suscept
sac
digest
fig
data
strongli
suggest
accumul
viru
carri
residu
infect
mice
day
pi
liver
day
pi
spleen
brain
learn
quickli
viru
accumul
variou
organ
mice
inocul
mice
ip
pfu
liver
spleen
brain
isol
everi
day
day
pi
elimin
possibl
contamin
sampl
use
laboratori
experi
sampl
viru
titer
product
rtpcr
product
suscept
rtpcr
product
sac
digest
summar
fig
repres
data
concern
sac
digest
rtpcr
product
shown
fig
sampl
carri
detect
level
infecti
virus
mani
sampl
viru
titer
detect
limit
yield
rtpcr
product
accumul
viru
detect
liver
singl
mous
earli
day
pi
viru
becam
major
viru
popul
liver
spleen
brain
day
pi
perform
sequenc
analysi
clone
rtpcr
product
firmli
establish
accumul
viru
mice
number
clone
use
sequenc
analysi
sampl
clone
mous
brain
clone
mous
spleen
clone
mous
brain
clone
mous
spleen
see
fig
consist
data
sac
digest
rtpcr
product
sampl
clone
data
unambigu
demonstr
viru
becam
major
viru
popul
mice
know
whether
phenomenon
emerg
major
popul
viru
infect
viru
also
occur
cell
cultur
independ
passag
five
time
multipl
infect
moi
cell
cell
rtpcr
product
includ
gener
intracellular
rna
extract
cell
infect
virus
passag
level
subject
sac
digest
observ
accumul
viru
passag
cell
type
data
shown
demonstr
viru
emerg
passag
cultur
cell
becam
major
viru
popul
mice
infect
final
examin
mous
virul
viru
accumul
mice
ip
inocul
pfu
brain
homogen
mous
see
fig
mice
n
dilut
rtpcr
analysi
mous
brain
extract
reveal
viru
major
viru
popul
sequenc
analysi
clone
rtpcr
product
brain
extract
show
inocul
pfu
recov
viru
result
death
mice
within
day
pi
mice
mice
mice
surviv
inocul
pfu
pfu
pfu
viru
respect
fig
recov
virus
higher
mous
virul
virul
fig
past
report
use
reassort
virus
attenu
strain
wt
rvfv
suggest
rvfv
virul
mous
polygen
control
past
studi
reveal
nss
gene
encod
segment
nsm
gene
encod
segment
contribut
viral
virul
present
find
singl
nucleotid
differ
gn
gene
substanti
affect
virul
mice
result
support
notion
rvfv
virul
polygen
control
roughli
mixtur
viru
viru
exist
viru
stock
origin
sampl
patient
rvfv
outbreak
avail
unclear
whether
high
titer
viru
viru
replic
patient
found
viru
becam
major
viral
popul
mice
inocul
virus
accumul
mice
inocul
viru
addit
isol
wt
rvfv
thu
far
report
found
carri
also
encod
data
suggest
viru
probabl
repres
major
viru
popul
patient
howev
possibl
viru
exist
rvfv
quasispeci
patient
affect
sever
diseas
quasispeci
cooper
interact
control
viral
pathogenesi
consist
notion
found
lesser
virul
viru
sampl
consist
major
popul
viru
minor
popul
fig
obtain
mous
brain
day
pi
fig
although
accumul
viru
occur
even
passag
cell
cell
observ
replic
higher
titer
cultur
cell
fig
trend
viru
replic
vitro
point
possibl
viru
present
minor
viru
popul
patient
could
amplifi
cell
cultur
becom
major
viral
subpopul
viru
stock
gener
vitro
kinet
viru
accumul
variou
organ
mice
inocul
show
rvfv
replic
liver
earli
infect
effici
replic
liver
initi
target
organ
probabl
induc
high
viremia
titer
facilit
spread
viru
organ
includ
spleen
kidney
brain
ultim
lead
death
anim
viru
titer
liver
mice
day
pi
roughli
ten
time
lower
liver
mice
fig
likewis
viru
titer
organ
serum
mice
substanti
lower
correspond
organ
mice
present
data
impli
level
viru
titer
initi
target
organ
eg
liver
day
pi
may
determin
sever
ultim
outcom
rvfv
infect
mice
although
demonstr
import
singl
nucleotid
substitut
gn
protein
wt
rvfv
mous
virul
studi
requir
determin
singl
nucleotid
substitut
affect
rvfv
virul
past
studi
show
gainofpositivecharg
mutat
flaviviru
e
protein
alphaviru
protein
enhanc
bind
neg
charg
glycosaminoglycan
gag
increas
effici
viru
uptak
cultur
cell
howev
virul
variant
virus
mice
reduc
variant
virus
rapidli
clear
circulatori
system
probabl
gainofpositivecharg
mutat
envelop
protein
facilit
viral
adher
gag
present
blood
cell
subsequ
reticuloendotheli
systemmedi
viru
elimin
circul
likewis
neg
charg
gn
envelop
protein
highli
virul
mice
carri
uncharg
substanti
less
virul
fig
furthermor
mice
show
higher
viremia
titer
mice
day
pi
fig
replic
higher
titer
cell
fig
accordingli
possibl
bind
effici
gag
circul
result
low
level
system
infect
wherea
carri
bind
gag
less
effici
result
high
titer
viremia
effici
establish
system
infect
involv
cn
kill
infect
mice
attenu
viru
develop
serial
passag
wt
rvfv
strain
presenc
carri
encod
suggest
presenc
gn
alway
make
rvfv
virul
amino
acid
sequenc
segment
differ
amino
acid
suspect
combin
mutat
amino
acid
segment
contribut
attenu
present
studi
show
import
nucleotid
wt
rvfv
mous
virul
wherea
unclear
whether
nucleotid
also
affect
viral
virul
anim
like
one
wt
rvfv
isol
obtain
abort
bovin
fetu
zimbabw
g
carri
gli
rest
wt
rvfv
isol
thu
far
sequenc
carri
encod
inform
avail
titer
differ
tissu
abort
fetu
viremia
statu
mother
although
report
pregnant
cow
inocul
becom
febril
pfuml
viremia
undergo
abort
relationship
level
viremia
abort
cattl
care
examin
yet
observ
low
viremia
result
abort
experiment
infect
sheep
j
morril
unpublish
data
henc
specul
placent
tissu
sheep
probabl
cattl
may
exquisit
sensit
infect
low
titer
viremia
infect
placenta
low
level
gain
access
fetu
virul
bovin
experiment
test
differ
genom
region
accordingli
role
g
viru
virul
bovin
unclear
experiment
infect
domest
anim
show
whether
import
nucleotid
viral
virul
limit
mous
model
remark
rapid
emerg
accumul
viru
occur
mice
inocul
fig
past
experiment
infect
use
swine
influenza
viru
result
similarli
rapid
emerg
variant
viru
infect
host
singl
infect
exampl
type
quasispeci
emerg
fixat
vivo
although
rescu
cdna
direct
sequenc
segment
show
presenc
inoculum
data
shown
virus
might
gener
polymerasemedi
primari
transcript
plasmid
segment
rna
replic
exist
one
minor
viru
popul
quasispeci
inoculum
altern
viru
gener
point
mutat
segment
mice
becam
major
viru
popul
earli
day
pi
discuss
specul
may
bind
gag
less
effici
put
phenotyp
viru
might
prevent
effici
elimin
viru
reticuloendotheli
system
facilit
continu
replic
system
infect
note
neutral
antibodi
rapidli
elicit
mice
within
day
pi
fig
time
virus
retain
genotyp
fig
import
neutral
antibodi
protect
anim
rvfv
infect
well
document
rapid
effici
gener
neutral
antibodi
probabl
contribut
low
titer
viremia
prevent
system
infect
mice
interest
note
antiserum
neutral
heterolog
viru
equal
lesser
degre
homolog
viru
cross
neutral
assay
tabl
result
consist
report
region
includ
gn
protein
major
neutral
epitop
site
like
mice
viru
emerg
partli
viru
less
suscept
rapidli
gener
neutral
antibodi
direct
suspect
mice
newli
emerg
viru
fail
continu
replic
effici
day
pi
variou
organ
primarili
due
increas
titer
neutral
antibodi
result
surviv
mice
viru
titer
mice
higher
inocul
mani
organ
first
day
pi
neutral
antibodi
titer
tend
higher
mice
mice
fig
data
suggest
replic
might
induc
immunosuppress
possibl
consist
data
lymphocyt
deplet
white
pulp
mice
inocul
inocul
find
probabl
due
apoptosi
fig
strain
wt
rvfv
obtain
special
pathogen
branch
center
diseas
control
prevent
cdc
atlanta
georgia
rvfv
origin
isol
patient
outbreak
rvfv
egypt
inocul
human
specimen
suckl
mice
brain
amplif
viru
suckl
mice
brain
one
time
viru
stock
gener
two
passag
frhl
cell
two
passag
cell
vero
cell
line
cell
line
use
viral
plaqu
assay
describ
previous
experi
use
virul
perform
robert
e
shope
md
laboratori
john
seali
pavilion
infecti
diseas
research
univers
texa
medic
branch
galveston
texa
standard
molecular
biolog
techniqu
use
construct
plasmid
total
rna
cell
infect
rvfv
obtain
stuart
nichol
cdc
use
firststrand
cdna
synthesi
viru
stock
cdc
stock
underw
passag
histori
pcr
fragment
fulllength
antiviralsens
lsegment
clone
plasmid
design
respect
msegment
carri
g
nucleotid
antiviralsens
clone
plasmid
design
respect
plasmid
express
n
l
protein
control
rna
polymeras
report
previous
orf
glycoprotein
carri
g
nucleotid
antiviralsens
clone
pcagg
plasmid
chicken
promot
design
pcaggsg
construct
confirm
expect
sequenc
recombin
carri
g
nucleotid
antiviralsens
recov
cotransfect
pcaggsg
cell
miru
madison
wi
describ
previous
recov
cotransfect
cell
cultur
medium
replac
fresh
medium
h
post
transfect
day
post
transfect
cultur
supernat
collect
clarifi
inocul
cell
supernat
infect
cell
day
pi
collect
use
titrat
viru
infect
plaqu
assay
subsequ
experi
sequenc
analysi
segment
rna
confirm
presenc
expect
nucleotid
intracellular
viral
rna
infect
cell
serv
sourc
sequenc
analysi
sequenc
l
rna
segment
rescu
determin
direct
sequenc
analysi
virusspecif
rtpcr
product
sequenc
viral
rna
free
intracellular
rna
remov
calf
intestin
alkalin
phosphatas
sampl
treat
tobacco
acid
pyrophosphatas
remov
cap
structur
ligat
rna
adaptor
uncap
rna
use
rna
ligas
cdna
synthes
employ
rlmrace
kit
ambion
austin
tx
use
random
primer
amplicon
obtain
use
virusspecif
adaptorspecif
primer
subject
sequenc
analysi
sequenc
viral
rna
poli
tail
ad
viral
rna
use
poli
polymeras
tail
kit
epicent
biotechnolog
madison
wi
firststrand
cdna
synthes
rna
contain
poli
tail
use
adaptor
rlmrace
kit
ambion
cdna
subject
pcr
adaptorspecif
primer
virusspecif
primer
amplicon
subject
sequenc
analysi
cell
mous
cell
mous
macrophagederiv
cell
cell
infect
virus
moi
h
wash
time
pb
medium
ad
cultur
supernat
harvest
variou
time
pi
viru
titer
measur
plaqu
assay
viru
titer
determin
plaqu
assay
vero
cell
monolay
grown
plate
viral
plaqu
assay
serial
tenfold
dilut
specimen
prepar
hbss
fetal
bovin
serum
ad
hbssfb
dilut
adsorb
duplic
cell
monolay
hour
hour
monolay
overlaid
ml
mixtur
part
agaros
part
eagl
basal
medium
earl
salt
mm
hepe
fetal
bovin
serum
u
penicillinml
streptomycin
sulfateml
incub
h
atmospher
cell
monolay
stain
ad
ml
second
overlay
ident
first
contain
neutral
red
addit
h
incub
plaqu
enumer
viral
titer
calcul
fiveweekold
femal
outbr
mice
purchas
charl
river
laboratori
wilmington
mice
hous
mice
per
cage
microisol
cage
biolog
contain
laboratori
daynight
photoperiod
viru
inocula
prepar
hbss
ph
supplement
mous
inocul
ip
ml
inoculum
tuberculin
syring
fit
inch
needl
moribund
mice
mice
preselect
euthanasia
anesthet
isofluran
whole
blood
collect
via
cardiac
punctur
mice
euthanat
cervic
disloc
liver
spleen
brain
tissu
asept
collect
immedi
follow
euthanasia
soon
dead
mice
discov
experi
perform
accord
guidelin
institut
anim
care
use
committe
univers
texa
medic
branch
recommend
guid
care
use
laboratori
anim
institut
laboratori
anim
resourc
nation
research
council
nation
academi
scienc
facil
use
fulli
accredit
american
associ
accredit
laboratori
anim
care
tissu
prepar
wv
homogen
hbss
supplement
heatinactiv
minut
fetal
bovin
serum
antibiot
uml
penicillin
streptomycin
serum
viru
neutral
antibodi
assay
separ
whole
blood
centrifug
x
g
minut
store
assay
tissu
homogen
similarli
clarifi
centrifug
supernat
harvest
store
assay
serum
neutral
antibodi
determin
use
plaquereduct
neutral
test
serial
fourfold
dilut
serum
prepar
hbssfb
equal
volum
strain
rvfv
suspens
contain
approxim
ad
dilut
incub
hr
dilut
adsorb
duplic
vero
cell
monolay
hr
overlaid
ml
agarosemedium
mixtur
use
viral
plaqu
assay
hr
incub
atmospher
monolay
receiv
ml
second
agaros
contain
neutral
red
dye
plaqu
count
reduct
number
plaqu
inocul
use
endpoint
virusneutr
titer
serum
demonstr
titer
mixtur
sera
collect
day
pi
eight
mice
similarli
serum
demonstr
titer
mixtur
sera
collect
day
pi
four
mice
diluent
hbssfb
normal
mous
serum
serv
neg
control
convalesc
goat
serum
show
titer
serv
posit
control
incub
overnight
vial
contain
approxim
pfuml
combin
serum
sampl
diluent
incub
viru
titer
determin
use
viral
plaqu
assay
one
hundr
microlit
tissu
homogen
mix
trizol
reagent
invitrogen
carlsbad
ca
addit
chloroform
tube
shaken
vigor
hand
centrifug
rpm
min
follow
centrifug
aqueou
phase
transfer
new
tube
isopropanol
ad
tube
sampl
centrifug
rpm
min
rna
pellet
wash
ethanol
dri
thirti
microlit
rnasefre
water
ad
dissolv
rna
pellet
sampl
treat
rnasefre
dnase
promega
madison
wi
rna
purifi
addit
phenolchloroform
total
rna
infect
cell
mous
liver
spleen
kidney
brain
extract
trizol
reagent
invitrogen
firststrand
cdna
synthes
random
hexam
rtg
youprim
rxn
bead
ge
healthcar
buck
uk
accord
manufactur
instruct
pcr
primer
anneal
nucleotid
nucleotid
gca
ggg
att
gca
atg
gca
aag
ggc
aca
acc
antiviralsens
use
pcr
reaction
pcr
perform
cycl
sec
min
min
use
expand
high
fidel
pcr
system
roch
mannheim
germani
pcr
product
purifi
qiaquick
pcr
purif
kit
qiagen
germantown
md
digest
sac
separ
agaros
gel
pcr
product
consist
wildtyp
msegment
directli
sequenc
clone
acceptor
vector
kit
novagen
darmstadt
germani
accord
manufactur
instruct
thirtyf
clone
sequenc
primer
specimen
histopatholog
examin
collect
neutral
buffer
formalin
liver
spleen
kidney
brain
obtain
infect
mice
control
anim
process
histopatholog
ihc
examin
previous
describ
formalinfix
paraffinembed
tissu
section
subject
hematoxylin
eosin
h
e
standard
method
evalu
histopatholog
ihc
stain
detect
rvfv
antigen
respect
detect
rvfv
antigen
tissu
incub
rabbit
antin
antibodi
color
develop
use
fuchsin
substratechromogen
system
dako
cytom
carpentaria
ca
